Abstract
BackgroundThe mouse protein Fv1 is a factor that can confer resistance to retroviral infection. The two major Fv1 alleles from laboratory mice, Fv1n and Fv1b, restrict infection by different murine leukaemia viruses (MLVs). Fv1n restricts B-tropic MLV, but not N-tropic MLV or NB-tropic MLV. In cells expressing Fv1b at natural levels, only N-MLV is restricted, however restriction of NB-MLV and partial restriction of B-MLV were observed when recombinant Fv1b was expressed from an MLV promoter in Fv1 null Mus dunni tail fibroblast cells. To investigate the relationship between expression level and restriction specificity we have developed new retroviral delivery vectors which allow inducible expression of Fv1, and yet allow sufficient production of fluorescent reporter proteins for analysis in our FACS-based restriction assay.ResultsWe demonstrated that at concentrations close to the endogenous expression level, Fv1b specifically restricts only N-MLV, but restriction of NB-MLV, and to a lesser extent B-MLV, could be gained by increasing the protein level of Fv1b. By contrast, we found that even when Fv1n is expressed at very high levels, no significant inhibition of N-MLV or NB-MLV could be observed. Study of Fv1 mutants using this assay led to the identification of determinants for N/B tropism at an expression level close to that of endogenous Fv1n and Fv1b. We also compared the recently described restriction activities of wild mice Fv1 proteins directed against non-MLV retroviruses when expressed at different levels. Fv1 from M. spretus restricted N-MLV, B-MLV and equine infectious anaemia virus equally even at low concentrations, while Fv1 from M. macedonicus showed even stronger restriction against equine infectious anaemia virus than to N-MLV. Restriction of feline foamy virus by Fv1 of M. caroli occurred at levels equivalent to MLV restriction.ConclusionsOur data indicate that for some but not all Fv1 proteins, gain of restriction activities could be achieved by increasing the expression level of Fv1. However such a concentration dependent effect is not seen with most Fv1s and cannot explain the recently reported activities against non-MLVs. It will be interesting to examine whether overexpression of other capsid binding restriction factors such as TRIM5α or Mx2 result in novel restriction specificities.Electronic supplementary materialThe online version of this article (doi:10.1186/s12977-016-0276-7) contains supplementary material, which is available to authorized users.
Highlights
The mouse protein Fv1 is a factor that can confer resistance to retroviral infection
Fv1n is present in NIH-Swiss mice, which are permissive to infection by N-tropic murine leukaemia viruses (MLVs) (N-MLV), but resistant to infection by B-tropic MLV (B-MLV)
Novel vectors to study restriction activities of Fv1 at different expression levels To examine the relationship between Fv1 expression levels and restriction specificity, we wanted to study the restriction of different MLVs at different concentrations of Fv1n and Fv1b, including both endogenous and overexpression levels, using our two-colour FACS-based restriction assay [5]
Summary
The mouse protein Fv1 is a factor that can confer resistance to retroviral infection. The two major Fv1 alleles from laboratory mice, Fv1n and Fv1b, restrict infection by different murine leukaemia viruses (MLVs). A lengthy period of coevolution between retroviruses and their hosts has resulted in the emergence of numerous host defence mechanisms, as well as viral countermeasures These include a number of factors such as Fv1, Trim5α, Trim5Cyp and Mx2 that restrict infection through interaction with the retroviral cores [1,2,3,4]. Normal levels of Fv1 are low [39] and restriction can be overcome by pre-exposure to MLV [40] Despite this Fv1 can represent a substantial barrier to MLV-induced leukemogenesis [41]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.